Summary
In rats with unilateral lesion of the nigrostriatal dopaminergic pathway, L-DOPA induces contralateral turning through activation of denervated D-1 and D-2 receptors. Blockade of N-methyl-D-aspartate (NMDA) receptors by the non-competitive antagonist (+)MK-801, potentiated the contralateral turning induced by L-DOPA as well as that induced by the D-1 agonist SKF 38393, while D-2 mediated turning was almost completely inhibited. Administration of the D-1 antagonist SCH 23390 blocked (+)MK-801-induced potentiation of L-DOPA contralateral turning, confirming the D-1 nature of the effects observed. Immunohistochemical studies on the early gene c-fos, which is known to be activated by stimulation of supersensitive D-1 receptors, revealed sparse c-fos positive nuclei in the lesioned CPu after SKF 38393, while after combined administration of (+)MK-801 and SKF 38393 dense labelling was obtained. Blockade of NMDA receptors, differentially affects D-1 and D-2 mediated turning behavior, suggesting that different neuronal pathways are involved in the mediation of D-1 and D-2 responses.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Calabresi P, Mercuri N, Stanzione P, Stefani A, Bernardi G (1987) Neuroscience 20: 757–771
Carlsson M, Carlsson A (1989) J Neural Transm 77: 65–71
Cotman CW, Monaghan DT, Ottersen OP, Storm-Mathisen J (1987) TINS 10/7: 273–279
Dragunow MR, Peterson MR, Robertson HA (1987) Eur J Pharmacol 135: 113–114
Dragunow M, Faull RLM (1990) Neurosci Lett 111: 39–45
Fagg GE, Foster AC (1983) Neuroscience 9/4: 701–719
Freund TF, Powell JF, Smith AD (1984) Neuroscience 13/4: 1189–1215
Garau L, Govoni S, Stefanini E, Trabucchi M, Spano PF (1978) Life Sci 23: 1745–1750
Gerfen CR, Engber TM, Susel Z, Mahan LC, Monsma FJ, Mcvittie LD, Sibley DR (1990) Soc Neurosci Abstr 2: 954
Halpain S, Girault J-A, Greengard P (1990) Nature 343: 369–371
Herrera-Marschitz M, Ungerstedt U (1984) Brain Res 323: 269–278
Kebabian JW, Calne DB (1979) Nature 277: 93–96
Klockgether T, Turski L (1990) Ann Neurol 28: 539–546
Kornhuber J, Kornhuber ME (1986) Life Sci 39: 669–674
Lodge D, Anis NA (1982) Eur J Pharmacol 77: 203–204
Maura G, Giardi A, Raiteri M (1988) J Pharmacol Exp Therap 247/2: 680–684
Mitchell IJ, Brotchie JM, Graham WC, Page RD, Robertson RG, Sambrook MA, Crossman AR (1991) The basalganglia III. Plenum Press, New York London
Morelli M, Di Chiara G (1990 a) Psychopharmacol 101: 287–288
Morelli M, Di Chiara G (1990 b) Eur J Pharmacol 182: 611–612
Morgan JI, Curran T (1986) Nature 322: 552–555
Onali P, Olianas MC, Gessa GL (1985) Mol Pharmacol 28: 138–145
Pellegrino LJ, Pellegrino AS, Cushman AJ (1979) Plenum Press, New York
Robertson HA, Peterson MR, Murphy K, Robertson GS (1989) Brain Res 503: 346–349
Robertson GS, Vincent SR, Fibiger HC (1990) Brain Res 523: 288–290
Smith AD, Bolam JP (1990) TINS 13/7: 259–265
Trugman JM, Wooten GF (1987) J Neurosci 7/9: 2927–2935
Ungerstedt U (1971) Acta Physiol Scand [Suppl] 367: 69–93
Walaas I (1981) Neuroscience 6/3: 399–405
Wong EHF, Knight AR, Woodruff GN (1988) J Neurochem 50: 74–81
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Morelli, M., Fenu, S., Pinna, A. et al. Blockade ofNMDA receptors differentially affectsD-1 andD-2 mediated turning behavior in the 6-hydroxydopamine model of Parkinson. Amino Acids 1, 205–213 (1991). https://doi.org/10.1007/BF00806918
Issue Date:
DOI: https://doi.org/10.1007/BF00806918